| |
| |
|
| Insider
Information: |
Bowden Christopher |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
59,654 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$515,420 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
59,654 |
|
|
| Total
Value |
$515,420 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Medical Officer |
2021-06-18 |
15,487 |
2015-06-01 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2022-06-22 |
44,167 |
2021-03-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
44,167 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-18 |
4 |
AS |
$60.11 |
$2,914,851 |
D/D |
(48,493) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-18 |
4 |
OE |
$39.76 |
$2,423,991 |
D/D |
48,493 |
63,980 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-17 |
4 |
AS |
$60.02 |
$150,170 |
D/D |
(2,502) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-17 |
4 |
OE |
$39.76 |
$99,480 |
D/D |
2,502 |
17,989 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-10 |
4 |
AS |
$60.06 |
$1,252,437 |
D/D |
(20,853) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-10 |
4 |
OE |
$39.76 |
$829,115 |
D/D |
20,853 |
36,340 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-09 |
4 |
OE |
$39.76 |
$284,244 |
D/D |
7,149 |
22,636 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-09 |
4 |
AS |
$60.16 |
$430,117 |
D/D |
(7,149) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-08 |
4 |
AS |
$60.07 |
$400,939 |
D/D |
(6,675) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-08 |
4 |
OE |
$39.76 |
$265,398 |
D/D |
6,675 |
22,162 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-07 |
4 |
AS |
$60.04 |
$256,232 |
D/D |
(4,268) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-06-07 |
4 |
OE |
$39.76 |
$169,696 |
D/D |
4,268 |
19,755 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-04-20 |
4 |
AS |
$55.11 |
$793,582 |
D/D |
(14,401) |
15,487 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-04-20 |
4 |
OE |
$35.16 |
$515,024 |
D/D |
14,401 |
29,888 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-04-19 |
4 |
OE |
$35.16 |
$112,864 |
D/D |
3,210 |
18,697 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-04-19 |
4 |
AS |
$55.16 |
$177,055 |
D/D |
(3,210) |
15,487 |
0 |
% |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,167 |
4,167 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(986) |
15,410 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,334 |
16,396 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,069) |
13,062 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
15,131 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
12,381 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-05-20 |
4 |
AS |
$50.01 |
$179,200 |
D/D |
(3,583) |
8,306 |
0 |
% |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Medical Officer |
• – – |
2020-05-20 |
4 |
OE |
$35.16 |
$125,978 |
D/D |
3,583 |
11,889 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
